Mushumo weTB we #WHO wazvino unoburitsa chokwadi chakajeka: vanhu vatsva vanosvika mamiriyoni 8.2 vakaonekwa vaine TB muna 2023—vakawanda zvikuru kubvira pakatanga kuongororwa pasi rose muna 1995. Kuwedzera uku kubva pamamiriyoni 7.5 muna 2022 kunodzosera TB semhondi huru yezvirwere zvinotapukira, kupfuura COVID-19.
Asi, dambudziko rakatonyanya kuoma rinofukidza kumuka uku:kuramba utachiona (AMR)WHO inofungidzira kuti panosvika gore ra2050, AMR inogona kutivanhu vanosvika mamiriyoni gumi pagorepasi rose, neTB isingarapike nemishonga (DR-TB) iriyo dambudziko guru. Muna 2019 chete, AMR yakauraya vanhu mamiriyoni 1.3 zvakananga—kupfuura HIV/AIDS nemalaria zvakabatanidzwa—uye ikozvino ndiyochikonzero chechitatu chikuru cherufu pasi rosePasina kupindira, huwandu hwerufu runokonzerwa neAMR hunogona kusvika pamamiriyoni makumi matatu nemapfumbamwe panosvika gore ra2050kurasikirwa kwehupfumi kuri pamusoro$100 tiririyoni.
Nei Kuongororwa Nenguva Yakakodzera Kusingakurukurwi
Kurapika kweTB kunoenderana nekuwanikwa kwayo nekukurumidza uye kupiwa mishonga chaiyo. Zvisinei, kushandiswa zvisina kunaka kwemishonga inorwisa mabhakitiriya kwakakonzera kuti TB isingapindi mishonga yakawanda (MDR-TB) ikurumidze, zvichiita kuti hutachiona hunorapika huve njodzi dzinouraya.
TB isingarapike nemishonga ndiyo inonyanya kukonzera 1/3 yerufu rweAMR pasi rose..
Vanhu vakwegura vanotarisana nekuwedzera kwehuwandu hwevakafa neAMR(yakakwira ne80% kubvira muna 1990 pakati pevakuru).
Kuchinja kwemamiriro ekunze kunogonaKupararira kweAMR kwakawedzera ne2.4% panosvika 2050, zvichikanganisa matunhu ane mari shoma zvakanyanya.
WHO inokurudzira nekukurumidza kuti pave nekuvandudzwa kwekuongorora chirwere nekukurumidza kurwisa kushandiswa zvisina kunaka uye kuvhara mipata yekurapa
Macro & Micro-Test's CE-Certified Triple TB Kit: Zvishandiso Zvakarurama zveAMR Era
Mhinduro yedu inoenderana nehurongwa hweWHO hwekudzivirira AMR nekuita kutikuonekwa panguva imwe chete kwehutachiona hweTB + rifampicin (RIF) + insoniazid (INH) resistance—zvakakosha pakuderedza DR-TB.
Zvinhu Zvikuru:
Kumhanya & Kururama: Mhedzisiro mumaawa 2–2.5 nekududzirwa otomatiki (kudzidziswa kushoma kunodiwa).
Zvinangwa Zvakakwana:TB: jini reIS6110
Kudzivirira RIF: rpoB (507~533)
Kusagona kweINH: InhA, AhpC, katG 315
Kunzwa Kwakanyanya: Inoona mabhakitiriya mashoma se10/mL (TB) uye 150–200 mabhakitiriya/mL kuti ione zviratidzo zvekudzivirira chirwere.
WHO-Inotevedzera: Inosangana nemirairo yekutarisira DR-TB.
Kuenderana Kwakakura: Inoshanda nemasisitimu makuru ePCR (semuenzaniso, Bio-Rad CFX96, SLAN-96P/S).
Nei Izvi Zvichikosha:
Kukurumidza kuziva majini asingashande zvakanaka kunodzivirira kushandiswa kwemishonga inorwisa mabhakitiriya zvisina kunaka, kunoderedza kutapurirana,
Kudanwa Kwechiito
Kubatana kwekumuka kweTB neAMR kunoda zvishandiso zvinobatanidza kumhanya nemazvo. Zvishandiso zvedu zvinovhara musiyano uyu—zvichiita kuti kurapwa kutange nemazvo, kekutanga.
Dzidza zvimwe:
https://www.mmtest.com/mycobacterium-tuberculosis-nucleic-acid-and-rifampicin%ef%bc%8cisoniazid-resistance-product/
Bata nesu:marketing@mmtest.com
#IVD #PCR #AMRCrisis #Kusabatwa neMishonga #TB #ENDTB #MDRTB #Kuongororwa #Hutano Hwepasi Pose #WHO #Kuongororwa kweMacroMicro
Nguva yekutumira: Mbudzi-25-2025